CARsgen Therapeutics Holdings Limited (HKG:2171)
Hong Kong · Delayed Price · Currency is HKD 21.12
-1.08 (-4.86%)
Sep 10, 2025, 1:45 PM HKT
HKG:2171 Revenue
CARsgen Therapeutics Holdings had revenue of 50.96M CNY in the half year ending June 30, 2025. This brings the company's revenue in the last twelve months to 84.05M, up 1,225.65% year-over-year. In the year 2024, CARsgen Therapeutics Holdings had annual revenue of 39.43M.
Revenue (ttm)
84.05M CNY
Revenue Growth
+1,225.65%
P/S Ratio
133.50
Revenue / Employee
180.74K CNY
Employees
465
Market Cap
12.30B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 39.43M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 25.81M | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines AG | 35.81B |
| Hansoh Pharmaceutical Group Company | 14.45B |
| JD Health International | 71.34B |
| Innovent Biologics | 12.52B |
| Sino Biopharmaceutical | 33.49B |
| WuXi Biologics | 21.98B |
| Akeso | 2.75B |
| CSPC Pharmaceutical Group | 28.49B |